- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
AAV ProDUCTS & SERVICE
AAV TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
AAV5 vector system (AAV5 expression system, AAV5 packaging plasmid system ) (Amp and Kanamycin) (GeneMedi Owned)
GeneMedi (GM) AAV5 Vector system is including: 1) AAV5 Rep-Cap plasmid (AAV5-RC plasmid) 2) AAV Helper plasmid 3) AAV expression vectors (overexpression or shRNA).
You can produce AAV5 particle in 293T cell line in high titer using GeneMedi's AAV5 Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.
The tissue tropism of AAV5 vector has been validated in neuron (CNS), retina, lung and pancreas, with potential applications in tissue-specific gene therapy.
GeneMedi offers both Ampicillin (Amp) resistance and Kanamycin (Kan) resistance for the AAV Rep-Cap Plasmids, AAV expression Plasmids and AAV helper Plasmid.
Go to AAV
vector system
>>
Map Download
Product Description
| Cat.NO | Product Name | Organization Type | Price(In USD) | First Order Discount | First Order Discount Price |
|---|---|---|---|---|---|
| P-PK07 | AAV5 Vector System (Amp resistance) 1. AAV5 Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Academic | 2028 | 50% | 1014 |
| P-PK07 | AAV5 Vector System (Amp resistance) 1. AAV5 Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Biotech & Pharma & Medical Device & Diagnostics | 50% | ||
| P-PK07 | AAV5 Vector System (Amp resistance) 1. AAV5 Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
50% | ||
| P-PK07 | AAV5 Vector System (Amp resistance) 1. AAV5 Rep-Cap Plasmid, ≥10mg 2. AAV Helper Plasmid, ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-PK07-Kan | AAV5 Vector System (Kan resistance) 1. AAV5 Rep-Cap Plasmid (Kan resistance) , ≥10mg 2. AAV Helper Plasmid (Kan resistance) , ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (Kan resistance) (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-RC07 | AAV5 Rep-Cap
Plasmid (Amp resistance)
Size：5ug |
Academic | 935 | 50% | 467.5 |
| P-RC07 | AAV5 Rep-Cap
Plasmid (Amp resistance)
Size：5ug | Biotech & Pharma & Medical Device & Diagnostics | 50% | ||
| P-RC07 | AAV5 Rep-Cap
Plasmid (Amp resistance)
Size：5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
50% | ||
| P-RC07 | AAV5 Rep-Cap
Plasmid (Amp resistance)
Size：≥10mg |
All | |||
| P-RC07-Kan | AAV5 Rep-Cap
Plasmid(Kan resistance)
Size：≥10mg |
All | |||
|
GeneMedi offers both seed and amplification services for the Amp-resistant AAV Vector System. GeneMedi only offers amplification services and do not provide seed for the Kan-resistant AAV Vector System currently. |
|||||
| If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service. | |||||
|
Terms of sale: For Seed (5ug): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for any other party. For plasmid production& amplification (≥10mg): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for themselves or any other party. |
|||||
Citation
| Title | Publication | Date |
|---|---|---|
| Local hyperthermia therapy induces browning of white fat and treats obesity | CELL | 2022/3/4 |
| Targeting E3 Ubiquitin-Ligase WWP1 Prevents Cardiac Hypertrophy Through Destabilizing DVL2 via Inhibition of K27-Linked Ubiquitination | CIRCULATION | |
| KIAA1429 promotes tumorigenesis and gefitinib resistance in lung adenocarcinoma by activating the JNK/MAPK pathway in an m6A-dependent manner | Drug Resistance Updates | 2022/12/5 |
| MYL3 protects chondrocytes from senescence by inhibiting clathrin-mediated endocytosis and activating of Notch signaling | Nature Communications | 2023/10/4 |
| atg7-Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity | Circulation Research | 2021/8/13 |
| Upregulation of Wilms’ Tumor 1 in epicardial cells increases cardiac fibrosis in dystrophic mice | CELL DEATH AND DIFFERENTIATION | 2022/3/19 |
| Paracrine FGFs target skeletal muscle to exert potent anti-hyperglycemic effects | Nature Communications | 2021/12/14 |
| Crystalline silica-induced macrophage pyroptosis interacting with mitophagy contributes to pulmonary fibrosis via modulating mitochondria homeostasis | Journal of Hazardous Materials | 2023/5/3 |
| CircEPS15, as a sponge of MIR24-3p ameliorates neuronal damage in Parkinson disease through boosting PINK1-PRKN-mediated mitophagy | Autophagy | 2023/4/10 |
| Exosomal circTUBGCP4 promotes vascular endothelial cell tipping and colorectal cancer metastasis by activating Akt signaling pathway | Journal of Experimental & Clinical Cancer Research | 2023/2/15 |
Validation data
No data found
Associated products and services
| Products & Service | Products & Service Information |
|---|---|
| AAV Packaging service | Detail |
| Promise-ORF™ viral CDNA library | Detail |
| Plasmid DNA Rapid Preparation Service | Detail |
Facebook
LinkedIn
Twitter
